Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA vs VENUS REMEDIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ORCHID PHARMA VENUS REMEDIES ORCHID PHARMA/
VENUS REMEDIES
 
P/E (TTM) x 41.8 15.0 277.9% View Chart
P/BV x 7.7 0.9 812.2% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 ORCHID PHARMA   VENUS REMEDIES
EQUITY SHARE DATA
    ORCHID PHARMA
Mar-23
VENUS REMEDIES
Mar-23
ORCHID PHARMA/
VENUS REMEDIES
5-Yr Chart
Click to enlarge
High Rs439379 115.7%   
Low Rs273145 188.3%   
Sales per share (Unadj.) Rs163.1415.5 39.3%  
Earnings per share (Unadj.) Rs13.519.9 68.1%  
Cash flow per share (Unadj.) Rs27.044.0 61.2%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs168.7344.3 49.0%  
Shares outstanding (eoy) m40.8213.37 305.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.20.6 346.0%   
Avg P/E ratio x26.313.2 199.4%  
P/CF ratio (eoy) x13.25.9 221.9%  
Price / Book Value ratio x2.10.8 277.2%  
Dividend payout %00-   
Avg Mkt Cap Rs m14,5223,501 414.8%   
No. of employees `000NANA-   
Total wages/salary Rs m654570 114.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m6,6595,555 119.9%  
Other income Rs m194103 188.2%   
Total revenues Rs m6,8535,658 121.1%   
Gross profit Rs m1,235602 205.2%  
Depreciation Rs m548323 169.6%   
Interest Rs m3293 11,191.2%   
Profit before tax Rs m552379 145.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m0114 0.0%   
Profit after tax Rs m552266 208.0%  
Gross profit margin %18.510.8 171.1%  
Effective tax rate %030.0 0.0%   
Net profit margin %8.34.8 173.5%  
BALANCE SHEET DATA
Current assets Rs m5,0103,230 155.1%   
Current liabilities Rs m3,719826 450.4%   
Net working cap to sales %19.443.3 44.8%  
Current ratio x1.33.9 34.4%  
Inventory Days Days5737 155.3%  
Debtors Days Days1,180504 234.2%  
Net fixed assets Rs m7,2422,781 260.4%   
Share capital Rs m408134 305.3%   
"Free" reserves Rs m6,4784,470 144.9%   
Net worth Rs m6,8864,603 149.6%   
Long term debt Rs m1,488387 384.8%   
Total assets Rs m12,2526,011 203.8%  
Interest coverage x2.7130.0 2.1%   
Debt to equity ratio x0.20.1 257.2%  
Sales to assets ratio x0.50.9 58.8%   
Return on assets %7.24.5 161.0%  
Return on equity %8.05.8 139.0%  
Return on capital %10.57.7 137.4%  
Exports to sales %81.90-   
Imports to sales %37.60-   
Exports (fob) Rs m5,452NA-   
Imports (cif) Rs m2,501NA-   
Fx inflow Rs m5,4520-   
Fx outflow Rs m2,7260-   
Net fx Rs m2,7260-   
CASH FLOW
From Operations Rs m183366 50.1%  
From Investments Rs m-312-508 61.4%  
From Financial Activity Rs m312-6 -5,487.0%  
Net Cashflow Rs m183-220 -83.0%  

Share Holding

Indian Promoters % 69.8 41.8 167.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 18.6 1.6 1,172.3%  
FIIs % 4.1 1.6 260.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.2 58.2 51.8%  
Shareholders   36,931 19,560 188.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ORCHID PHARMA With:   SUN PHARMA    CIPLA    DIVIS LABORATORIES    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Orchid Pharma vs VENUS REMEDIES

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Orchid Pharma vs VENUS REMEDIES Share Price Performance

Period Orchid Pharma VENUS REMEDIES S&P BSE HEALTHCARE
1-Day -0.40% 7.05% 1.18%
1-Month -14.06% -4.10% -0.75%
1-Year 173.54% 103.11% 61.82%
3-Year CAGR -23.64% 4.62% 18.16%
5-Year CAGR 184.58% 58.05% 19.79%

* Compound Annual Growth Rate

Here are more details on the Orchid Pharma share price and the VENUS REMEDIES share price.

Moving on to shareholding structures...

The promoters of Orchid Pharma hold a 69.8% stake in the company. In case of VENUS REMEDIES the stake stands at 41.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Orchid Pharma and the shareholding pattern of VENUS REMEDIES.

Finally, a word on dividends...

In the most recent financial year, Orchid Pharma paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

VENUS REMEDIES paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of Orchid Pharma, and the dividend history of VENUS REMEDIES.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.